Join the club for FREE to access the whole archive and other member benefits.

Boris Djordjevic

Chief Executive Officer at the 199 Biotechnologies

Boris is a specialist in autologous treatments and a has been involved in the field of ageing research for over 15 years. Boris has a deep understanding of the latest developments and technologies in aesthetic and longevity medicine. His passion for helping people look and feel their best is evident in every aspect of the clinic, from the personalised care we provide to the cutting-edge treatments we offer. Boris is dedicated to helping his clients achieve their goals through safe and effective treatments that produce natural-looking results.

Visit website:


See also: Company 199 Biotechnologies - Company that develops therapies to slow, halt and reverse ageing

Details last updated 06-Aug-2023

Boris Djordjevic is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Heales (Healthy Life Extension Society)

Stimulating, promoting and informing the public about life extension